Delivery Order SPE2DM20D2004-SPE2DM25FA7BT
- Not listed
- Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $2,663.06 for the supply of Agent Hemostatic Thrombin Sterile Kit Matrix Surgiflo 8 medical products. This firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed in Waukegan, Illinois. The award represents a no-set-aside competitive procurement and falls under Cardinal...
- Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order valued at $2,779.76 by the Defense Logistics Agency (DLA) on July 21, 2025, for Agent Hemostatic Thrombin Starch Kit Matrix Surgiflo 8 medical supplies. This firm fixed-price delivery order, which is not set aside for any specific business category, will be performed in Waukegan, Illinois, with an ultimate completion date of July 22, 2025. The award represents a single-item procurement under the DLA's...
- Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. and a major supplier of medical products to federal healthcare systems, was awarded a delivery order valued at $6,530.50 by the Defense Logistics Agency on July 21, 2025. The delivery order is for Agent Hemostatic Thrombin Surgical Kit Matrix Surgiflo 8, a specialized surgical hemostatic agent used in medical procedures to control bleeding. This is a firm fixed-price delivery order with no set-aside designation, meaning Cardinal...
- Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract, valued at $1,320.33, is for the delivery of an agent hemostatic thrombin stasis matrix product (Surgiflo 8), a specialized surgical hemostatic agent used in medical procedures. This is a firm fixed-price delivery order with no set-aside designation, indicating that...
- Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. and a major supplier of medical products to federal healthcare systems, was awarded a delivery order valued at $15,194.52 on July 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is firm fixed price and requires completion by July 28, 2025, covers Agent Hemostatic Thrombin Sealant Matrix Surgiflo 8 surgical supplies to be delivered to Waukegan, Illinois. This delivery order was awarded...
- Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. and a major healthcare products supplier to federal agencies, was awarded a delivery order valued at $5,525.28 by the Defense Logistics Agency's Medical Supply Chain on July 18, 2025. The delivery order, issued under a firm fixed-price arrangement with no set-aside designation, covers Agent Hemostatic Thrombin Stryker Kit Matrix SurgiFlow 8 medical supplies. The contract is set to be completed by July 21, 2025, with the place of...
- The Defense Logistics Agency awarded a Firm Fixed Price Delivery Order contract worth $1,342.14 to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of Surgiflo Hemostatic Matrix products, which are medical supplies used for surgical procedures. This Delivery Order contract is part of the larger single-award Indefinite Delivery Contract SPE2DV held by Cardinal Health 200 with the Defense Logistics Agency, allowing the agency to procure up to $5...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract, identified as SPE2DM20D2007|SPE2DM25FG6GH, is for the delivery of medical supplies, including agent hemostatic thrombotic sterile kits, matrix Surgiflo 8. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,663.06 and an ultimate completion date of May 12, 2025. Cardinal Health 200, LLC is a for-profit limited liability...
- Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a delivery order valued at $1,315.06 by the Defense Logistics Agency (DLA) for the procurement of Agent HMST Thrmb Strl Kt Mtrx Surgiflo 8 medical supplies. The contract, designated as a Firm Fixed Price delivery order, was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed in Waukegan, Illinois. This delivery order is not set-aside and represents a routine...
- The Defense Logistics Agency (DLA) awarded a $27,658.40 firm-fixed-price delivery order to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., to provide an agent hemostatic thrombosis control kit matrix and Surgiflo medical supplies. This delivery order is part of Cardinal Health 200's existing single-award Indefinite Delivery Contract (IDC) with DLA, which allows the agency to rapidly obtain needed medical consumables such as surgical dressings, drugs, biologicals, and other...
- SPE2DM20D2004Indefinite Delivery Contract
- SPE2DM20D2004-SPE2DM25FA7BTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,389.88 to Cardinal Health 200, LLC for an Agent Hemostatic Thrombin Styptic Kit Matrix Surgiflo 8 product on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order was not set aside and represents a relatively small procurement under Cardinal Health 200, LLC's larger indefinite delivery contract with DLA. The place of performance is Waukegan, Illinois. Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., is a major healthcare services and products company specializing in medical supplies and equipment for federal government agencies, particularly military treatment facilities and Department of Defense healthcare providers. This delivery order falls under Cardinal Health 200, LLC's existing Indefinite Delivery Contract with DLA (SPE2DV), which carries a $4.99 million ceiling and runs through August 27, 2027. The company maintains a significant portfolio of medical supply contracts with various federal agencies, demonstrating its established role as a critical supplier of surgical consumables, wound care products, and specialized medical kits to the defense and veteran healthcare systems. The Surgiflo hemostatic agent is a specialized surgical product used in medical procedures to support hemorrhage control, reflecting DLA's ongoing procurement of critical medical supplies for military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/25/25 |